Meril
A global medical technology company that designs, manufactures, and distributes a diverse range of clinically relevant medical devices, including vascular intervention solutions, orthopedic implants, and surgical robotics.
- CEO / Founder
- Vivek Shah
- Team Size
- 10000+
- Stage
- Active
- Total Funding
- $370.0M
- Latest Round
- Private Equity
- Key Investors
- Warburg Pincus, Temasek Holdings, Abu Dhabi Investment Authority (ADIA)
Technology & Products
Key Products
Vascular intervention devices, orthopedic implants, surgical robotics
Technological Advantage
Pioneered India's first domestically produced bioresorbable scaffold and surgical robot; utilizes advanced Additive Manufacturing (3D printing) for customized orthopedic implants and thin-strut technology for vascular stents.
Differentiation
Value Proposition
Delivers high-quality, state-of-the-art medical devices at accessible price points by leveraging large-scale vertical integration and indigenous R&D to alleviate human suffering globally.
How They Differentiate
Meril differentiates through 'Value-Innovation,' offering high-tech medical devices (like TAVR valves and surgical robots) at 30-40% lower costs than Western competitors. This is achieved through extreme vertical integration, where R&D, design, and large-scale manufacturing are all handled in-house in India.
Market & Competition
Target Customers
Hospitals, specialized surgical centers, healthcare professionals (cardiologists, orthopedic surgeons), and global healthcare procurement agencies.
Industry Verticals
["Medical Devices","Healthcare Technology","Cardiovascular Health","Orthopedics","Robotic Surgery","Diagnostics"]
Competitors
Medtronic, Edwards Lifesciences, Stryker, Zimmer Biomet
Growth & Milestones
Growth Metrics
Estimated annual revenue of $350M - $500M; maintains a portfolio of over 100,000 SKUs and has achieved a valuation of approximately $2.5B following recent investments.
Major Milestones
["2018: Received CE Mark for Myval, becoming the first Indian company to launch an indigenous Transcatheter Aortic Valve Replacement (TAVR) system.","2022: Secured $210M from Warburg Pincus, marking its first major external funding round.","2023: Launched MISSO, India's first indigenous surgical robotic system for knee replacement.","2024: Secured $160M from Temasek and ADIA to accelerate global expansion and R&D."]
Notable Customers
Apollo Hospitals, Fortis Healthcare, Max Healthcare, National Health Service (NHS) UK